Mark R. Green

Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial

Kathy S. Albain, Ruth Swann, Valerie W. Rusch et al. · The Lancet · 2009 · 1.5K citations · Full text

Surgical Oncology, Surgical Resection, Radiation Therapy +8

A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer

Robert O. Dillman, Stephen L. Seagren, Kathleen J. Propert et al. · New England Journal of Medicine · 1990 · 1.2K citations · Full text

Chemotherapy of Advanced Hodgkin's Disease with MOPP, ABVD, or MOPP Alternating with ABVD

George P. Canellos, James R. Anderson, Kathleen J. Propert et al. · New England Journal of Medicine · 1992 · 1.2K citations · Full text

Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups

Gary M. Strauss, James E. Herndon, Michael A. Maddaus et al. · Journal of Clinical Oncology · 2008 · 975 citations · Full text

Irinotecan Plus Gemcitabine Results in No Survival Advantage Compared With Gemcitabine Monotherapy in Patients With Locally Advanced or Metastatic Pancreatic Cancer Despite Increased Tumor Response Rate

Caio M. Rocha Lima, Mark R. Green, Robert Rotche et al. · Journal of Clinical Oncology · 2004 · 580 citations · Full text